These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 25976907)

  • 21. Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey.
    Bongiorni MG; Proclemer A; Dobreanu D; Marinskis G; Pison L; Blomstrom-Lundqvist C;
    Europace; 2013 Nov; 15(11):1664-8. PubMed ID: 24170423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods.
    Ritter P; Delnoy PP; Padeletti L; Lunati M; Naegele H; Borri-Brunetto A; Silvestre J
    Europace; 2012 Sep; 14(9):1324-33. PubMed ID: 22549295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy).
    Brenyo A; Link MS; Barsheshet A; Moss AJ; Zareba W; Wang PJ; McNitt S; Huang D; Foster E; Estes M; Solomon SD; Goldenberg I
    J Am Coll Cardiol; 2011 Oct; 58(16):1682-9. PubMed ID: 21982313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).
    Ruwald MH; Abu-Zeitone A; Jons C; Ruwald AC; McNitt S; Kutyifa V; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Oct; 62(15):1343-50. PubMed ID: 23770172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrioventricular and ventricular-to-ventricular programming in patients with cardiac resynchronization therapy: results from ALTITUDE.
    Steinberg BA; Wehrenberg S; Jackson KP; Hayes DL; Varma N; Powell BD; Day JD; Frazier-Mills CG; Stein KM; Jones PW; Piccini JP
    J Interv Card Electrophysiol; 2015 Dec; 44(3):279-87. PubMed ID: 26400764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impedance cardiography: a useful and reliable tool in optimization of cardiac resynchronization devices.
    Heinroth KM; Elster M; Nuding S; Schlegel F; Christoph A; Carter J; Buerke M; Werdan K
    Europace; 2007 Sep; 9(9):744-50. PubMed ID: 17496288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators: Groupe de Rythmologie et Stimulation Cardiaque de la Société Française de Cardiologie and Société Française de Gériatrie et Gérontologie.
    Fauchier L; Alonso C; Anselme F; Blangy H; Bordachar P; Boveda S; Clementy N; Defaye P; Deharo JC; Friocourt P; Gras D; Halimi F; Klug D; Mansourati J; Obadia B; Pasquié JL; Pavin D; Sadoul N; Taieb J; Piot O; Hanon O
    Arch Cardiovasc Dis; 2016 Oct; 109(10):563-585. PubMed ID: 27595465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term clinical effects of programmer-guided atrioventricular and interventricular delay optimization: Intracardiac electrography versus echocardiography for cardiac resynchronization therapy in patients with heart failure.
    Wang D; Yu H; Yun T; Zang H; Yang G; Wang S; Wang Z; Jing Q; Han Y
    J Int Med Res; 2013 Feb; 41(1):115-22. PubMed ID: 23569136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atrial high-rate episodes predict clinical outcome in patients with cardiac resynchronization therapy.
    Jacobsson J; Platonov PG; Reitan C; Carlsson J; Borgquist R
    Scand Cardiovasc J; 2017 Apr; 51(2):74-81. PubMed ID: 27841021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Case of a Cardiac Resynchronization Therapy-Defibrillator Exhibiting a Lower and Alternately Variable Basic Rate.
    Iwazaki K; Kojima T; Murasawa T; Yokota J; Tanimoto H; Matsuda J; Fukuma N; Matsubara T; Shimizu Y; Oguri G; Hasumi E; Kubo H; Chang K; Fujiu K; Komuro I
    Int Heart J; 2018 May; 59(3):626-629. PubMed ID: 29628471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute evaluation of programmer-guided AV/PV and VV delay optimization comparing an IEGM method and echocardiogram for cardiac resynchronization therapy in heart failure patients and dual-chamber ICD implants.
    Baker JH; McKenzie J; Beau S; Greer GS; Porterfield J; Fedor M; Greenberg S; Daoud EG; Corbisiero R; Bailey JR; Porterfield L
    J Cardiovasc Electrophysiol; 2007 Feb; 18(2):185-91. PubMed ID: 17338767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial.
    Singh JP; Klein HU; Huang DT; Reek S; Kuniss M; Quesada A; Barsheshet A; Cannom D; Goldenberg I; McNitt S; Daubert JP; Zareba W; Moss AJ
    Circulation; 2011 Mar; 123(11):1159-66. PubMed ID: 21382893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of left ventricular electrical delay on AV optimization for cardiac resynchronization therapy.
    Gold MR; Yu Y; Singh JP; Stein KM; Birgersdotter-Green U; Meyer TE; Seth M; Ellenbogen KA
    Heart Rhythm; 2013 Jul; 10(7):988-93. PubMed ID: 23499621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Goldenberg I; Hall WJ; Beck CA; Moss AJ; Barsheshet A; McNitt S; Polonsky S; Brown MW; Zareba W
    J Am Coll Cardiol; 2011 Aug; 58(7):729-37. PubMed ID: 21816309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up.
    Valzania C; Biffi M; Martignani C; Diemberger I; Bertini M; Ziacchi M; Bacchi L; Rocchi G; Rapezzi C; Branzi A; Boriani G
    Echocardiography; 2007 Oct; 24(9):933-9. PubMed ID: 17894571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Programmed versus effective VV delay during CRT optimization: when what you see is not what you get.
    Bogaard MD; Meine M; Doevendans PA
    Pacing Clin Electrophysiol; 2013 Apr; 36(4):403-9. PubMed ID: 23305237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of left ventricular electrical delay on the acute hemodynamic response with cardiac resynchronization therapy.
    Gold MR; Leman RB; Wold N; Sturdivant JL; Yu Y
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):624-30. PubMed ID: 24446891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.